[EN] FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS [FR] DERIVES HETEROARYLE CONDENSES UTILISABLES COMME INHIBITEURS DE KINASE P38, NOTAMMENT DANS LE TRAITEMENT DE POLYARTHRITE RHUMATOIDE
[EN] FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS [FR] DERIVES HETEROARYLE CONDENSES UTILISABLES COMME INHIBITEURS DE KINASE P38, NOTAMMENT DANS LE TRAITEMENT DE POLYARTHRITE RHUMATOIDE
[EN] HETEROARYL SUBSTITUTED BIPHENYL DERIVATIVES AS P38 KINASE INHIBITORS<br/>[FR] DERIVES DE BIPHENYL SUBSTITUES EN HETEROARYLE SOUS FORME D'INHIBITEURS DE P38 KINASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003093248A1
公开(公告)日:2003-11-13
Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
[EN] NICOTINAMIDE DERIVATES USEFUL AS P38 INHIBITORS<br/>[FR] DERIVES DE NICOTINAMIDE UTILES COMME INHIBITEURS DE P38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003068747A1
公开(公告)日:2003-08-21
Compounds of formula (I), are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
申请人:Angell Martyn Richard
公开号:US20060089393A1
公开(公告)日:2006-04-27
Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
申请人:Angell Martyn Richard
公开号:US20060122221A1
公开(公告)日:2006-06-08
Compounds of formula (I): wherein A is a 5-membered heteroaryl ring are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38, such as rheumatoid arthritis.
Compounds of formula (I):
are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.